BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3899922)

  • 1. Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.
    Uchida A; Klein E
    Immunol Lett; 1985; 10(3-4):177-81. PubMed ID: 3899922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B; Katz J; Hoshino T
    Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients.
    Yanagawa E; Uchida A; Kokoschka EM; Micksche M
    Cancer Immunol Immunother; 1984; 16(3):131-6. PubMed ID: 6200209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
    Uchida A; Micksche M; Hoshino T
    Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
    Christmas SE; Meager A; Moore M
    Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
    Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
    Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
    Richter M; Kazaniwsky N
    Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
    Yanagawa E; Uchida A; Micksche M
    Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A; Micksche M
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1370-8. PubMed ID: 2809371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K; Kano S; Takaku F; Okumura K
    J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cytotoxicity of human blood monocytes: production of monocyte cytotoxic factors (MCF) during interaction with tumor cells.
    Uchida A; Yanagawa E
    Immunol Lett; 1984; 8(6):311-6. PubMed ID: 6597126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
    Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
    Uchida A
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
    Itoh K; Platsoucas CD; Balch CM
    Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.